Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Kyntra Bio (KYNB) Net Margin (2016 - 2025)

Historic Net Margin for Kyntra Bio (KYNB) over the last 12 years, with Q3 2025 value amounting to 19868.22%.

  • Kyntra Bio's Net Margin fell 55041400.0% to 19868.22% in Q3 2025 from the same period last year, while for Sep 2025 it was 1778.74%, marking a year-over-year decrease of 17985400.0%. This contributed to the annual value of 1465.54% for FY2024, which is 13827700.0% up from last year.
  • As of Q3 2025, Kyntra Bio's Net Margin stood at 19868.22%, which was down 55041400.0% from 451.04% recorded in Q2 2025.
  • In the past 5 years, Kyntra Bio's Net Margin registered a high of 25372.36% during Q3 2024, and its lowest value of 4558.88% during Q1 2023.
  • For the 5-year period, Kyntra Bio's Net Margin averaged around 2387.57%, with its median value being 160.19% (2023).
  • Its Net Margin has fluctuated over the past 5 years, first skyrocketed by 255325500bps in 2024, then tumbled by -74367100bps in 2025.
  • Over the past 5 years, Kyntra Bio's Net Margin (Quarter) stood at 812.56% in 2021, then skyrocketed by 76bps to 193.37% in 2022, then soared by 165bps to 125.93% in 2023, then crashed by -210bps to 138.17% in 2024, then skyrocketed by 14480bps to 19868.22% in 2025.
  • Its Net Margin was 19868.22% in Q3 2025, compared to 451.04% in Q2 2025 and 1189.17% in Q1 2025.